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Abstract
OBJECTIVE—Epidemiological and clinical studies suggest that rates of antisocial behavior,
depression, and impulsive substance use are increased among individuals diagnosed with alcohol
dependence relative to those who are not. Thus, the present study conducted genome-wide linkage
scans of antisocial behavior, depression, and impulsive substance use in the University of
California at San Francisco Family Alcoholism Study.
METHODS—Antisocial behavior, depressive symptoms, and impulsive substance use were
assessed using three scales from the MMPI-2, the Antisocial Practices content scale (ASP), the
Depression content scale (DEP), and the revised MacAndrew Alcoholism scale (MAC-R).
Linkage analyses were conducted using a variance components approach.
RESULTS—Suggestive evidence of linkage to three genomic regions independent of alcohol and
cannabis dependence diagnostic status was observed: the ASP scale showed evidence of linkage to
chromosome 13 at 11 cM, the MAC-R scale showed evidence of linkage to chromosome 15 at 47
cM, and all 3 scales showed evidence of linkage to chromosome 17 at 57–58 cM.
CONCLUSIONS—Each of these regions has shown prior evidence of linkage and association to
substance dependence as well as other psychiatric disorders such as mood and anxiety disorders,
ADHD, and schizophrenia thus suggesting potentially broad relations between these regions and
psychopathology.
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Epidemiological (e.g., Grant and Harford, 1995; Grant et al., 2004; Kessler et al., 1997;
Regier et al., 1990; Stinson et al., 2005) and clinical studies (e.g., Babor et al., 1992;
Cloninger, 1987b; Hesselbrock et al., 1985; Morey and Blashfield, 1981; Ross et al., 1988)
suggest that rates of depression, antisocial personality disorder, and illicit substance use are
elevated among individuals diagnosed with alcohol dependence relative to individuals
without this diagnosis. Given these high rates of co-occurrence, samples selected for alcohol
dependence can be expected to be enriched for depression, antisocial behavior, and other
substance use disorders. Further, each of these associated phenotypes show substantial
genetic influences in their etiology as demonstrated by numerous twin studies (depression -
Cadoret et al., 1985; Kendler et al., 1994, antisocial behavior - Lyons et al., 1995; Slutske et
al., 1997, substance misuse - Kendler et al., 2003a; Tsuang et al., 1996). Thus, it is
reasonable to utilize populations selected for alcohol dependence to identify genetic loci that
contribute to the development of depression, antisocial behavior, and substance use
phenotypes.
Such an approach is not without risks, however. Twin studies suggest that a shared genetic
etiology is, in part, responsible for the phenotypic correlation between antisocial behavior
and alcohol dependence (Hicks et al., 2004; Kendler et al., 2003b). Similarly, shared genetic
influences have been reported to underlie the phenotypic correlations between mood and
anxiety disorders and alcohol dependence (Kendler et al., 1993; Khan et al., 2005; Wender
et al., 1986), and shared genetic influences have also been reported to underlie the
phenotypic correlations between illicit substance use and alcohol dependence (Han et al.,
1999; Young et al., 2006). Although such studies suggest that significant overlap exists in
the genetic risk associated with these phenotypes, they also demonstrate that unique genetic
influences contribute to their development. As a result, studies investigating the genetic
contributions to these phenotypes must be careful to evaluate the extent to which linked
genomic loci are due to the unique genetic etiologies of each phenotype and the extent to
which they are the result of a shared genetic etiology.
The present study builds upon our previous efforts using scales from the Minnesota
Multiphasic Personality Inventory - 2nd edition (MMPI-2; Butcher et al., 1989) to identify
genetic influences that contribute to the development of depressive symptoms, antisocial
behavior, and substance misuse (Gizer et al., 2010) and alcohol dependence (Gizer et al.,
2011) in the University of California at San Francisco Family Alcoholism Study (SFFAM).
Results from the former study suggested that the Depression (DEP), Antisocial Practices
(ASP), and MacAndrew Alcoholism-Revised (MAC-R) scales from the MMPI-2 yielded
quantitative measures of depression, antisocial behavior, and impulsive substance use,
respectively, that were elevated among individuals diagnosed with alcohol dependence
relative to those without the diagnosis in the SFFAM. Further, each scale showed evidence
of familial transmission suggesting their utility in molecular genetic studies.
The ASP scale of the MMPI-2 was designed to assess antisocial attitudes and behaviors
associated with psychopathy (Butcher et al., 1990), and has shown moderate correlations
with similar measures (Lilienfeld, 1996). The DEP scale is primarily composed of items
assessing an individual's feelings of inadequacy and low self-worth (Butcher et al., 1990). It
has shown moderate correlations with other depression measures such as the Beck
Depression Inventory (Ben-Porath et al., 1993; Boone, 1994). The MAC-R scale was
originally constructed to differentiate alcoholic outpatients from outpatients with other
psychiatric conditions (MacAndrew, 1965). Subsequent research has demonstrated that the
MAC-R assesses general substance misuse rather than alcoholism specifically and may be
more accurately interpreted as a measure of impulsive drug use and reward seeking (Allen,
1991; Greene and Garvin, 1988; MacAndrew, 1979). Reward seeking behavior, which refers
to an array of approach and consumption behaviors, is influenced by dopamine neurons in
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the mesolimbic pathway, which includes the nucleus accumbens and ventral tegmental area
(Ikemoto and Panksepp, 1999). Several drugs including cocaine and methamphetamine
directly stimulate this pathway, though research has shown that activities such as eating,
sexual behavior, and even aggression can stimulate this pathway as well (Berridge, 2004).
Thus, high reward-seeking behavior has been related to substance use disorders and
antisocial behavior, which are thought to result from dysregulation of the mesolimbic
pathway (Cloninger, 1987a).
To further explore the conclusion that the ASP, DEP, and MAC-R scales may represent
useful phenotypes for molecular genetic studies of antisocial behavior, depression, and
impulsive substance use, respectively, we conducted genome-wide linkage scans for each of
these scales in the present study. Because the SFFAM sample was selected for alcohol
dependence and previous studies of the SFFAM have also shown high rates of cannabis use
among the participants (Ehlers et al., 2010a; Ehlers et al., 2010b; Vieten et al., 2004), a
second set of linkage scans using alcohol and then cannabis dependence diagnoses as
covariates were conducted to determine the extent to which genetic loci identified in the
initial analyses were unique or shared with the etiology of alcohol or cannabis dependence.
The results of these analyses and the implications of these findings for future molecular
genetic studies of substance dependence are discussed.
Materials and Methods
The protocol for the study was approved by the Institutional Review Board at the University
of California at San Francisco. Each recruited individual was fully briefed on the nature of
the study and provided written informed consent prior to participation. Ongoing
management and analysis of study data has been approved by the Institutional Review Board
at the University of North Carolina at Chapel Hill.
Participants
Participants were recruited as part of the UCSF Family Alcoholism Study, a nationwide
study on the genetics of alcoholism and other substance dependence. In brief, probands were
sampled from the community through semi-targeted direct mail, a web site, press releases,
advertisements and from alumni of treatment centers across the nation. Probands were
invited to participate if they met screening criteria for alcohol dependence at some point in
their lifetime and had at least one sibling or both parents available to participate in the study.
With the permission of the proband, relatives were invited by mail to participate.
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) diagnoses of alcohol and
other substance (e.g., nicotine, cannabis, and stimulant) dependence were made using a
modified version of the Semi-Structured Assessment for the Genetics of Alcoholism
(SSAGA; Bucholz et al., 1994). Participants also completed the MMPI-2 (Butcher et al.,
1989). Scores from three scales from the DEP, ASP, and MAC-R scales were evaluated.
Probands with serious drug addictions (e.g., stimulants, cocaine, or opiates) and those who
reported any history of intravenous substance use were excluded given that the primary aim
of the UCSF Family Alcoholism Study was to identify genetic loci that conferred risk for
alcohol dependence. Probands were excluded if, upon screening, they reported a current or
past diagnosis of schizophrenia, bipolar disorder, or other psychiatric illness involving
psychotic symptoms (those with depressive and anxiety disorders were accepted); a life-
threatening illness; or an inability to speak and read English.
Two thousand five hundred and twenty-four individuals were enrolled in the UCSF Family
Alcoholism Study of which 1647 were included in the present study. Participants' mean age
was 49.9 ± 12.8 years. Racial distribution was 93% Caucasian, 3% Hispanic American, 2%
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African-American, and 1% each Native American and other. No attempt was made to
exclude or over sample minorities. Probands were 62% female. A total of 700 participants
met criteria only for DSM-IV Alcohol Dependence, 46 participants met criteria only for
DSM-IV Cannabis Dependence, and 169 participants met criteria for both disorders. Sample
means for the three MMPI scales were as follows: DEP - M = 51.19 ± 11.70, ASP - M =
49.48 ± 9.78, MAC-R - M = 52.48 ± 10.73. Correlations between these scales and Alcohol
and Cannabis Dependence are presented in Table 1.
DNA Collection and Genotyping
The DNA extraction procedure and genotyping protocol have been previously described
(Wilhelmsen et al., 2003). Briefly, DNA was isolated from whole blood using a commercial
kit (Gentra, Minneapolis, MN), and genotypes for a panel of microsatellite polymorphisms
were generated using fluorescently labeled polymerase chain reaction (PCR) primers (HD5,
version 2.0; Applied Biosystems, Foster City, CA). The HD5 panel set consisted of 811
markers with an average marker-to-marker distance of 4.6 cM (maximum, 14 cM) and an
average heterozygosity of greater than 77%. A small subset of markers was omitted from the
panel because of null alleles, irregular allele spacing or other problems with reproducibility.
None of the omitted markers were adjacent to other omitted markers.
The sizes of marker amplimers were determined (blinded to pedigree structure and subject
characteristics) from electropherograms produced with an ABI 3700 (Applied Biosystems,
Foster City, CA) using the Genotyper software package (ABI). All electropherograms were
visually inspected and exported from Genotyper in base pair sizes relative to the standard
measured to one hundredth of a base pair. Allele frequencies observed in the founders were
used for all analysis. The sex-averaged marker map order obtained from the manufacturer
was used and verified with the family data from the current sample.
Genotypes for autosomal markers were analyzed using the Pedigree Relationship Statistical
Test (PREST; McPeek and Sun, 2000) software to detect sample and pedigree structure
errors. Genotyping was repeated for any individual with a probable error, and problematic
genotypes were treated as missing if the error persisted. Fifteen families were identified with
pedigree structure errors, and five were resolved following re-genotyping. The program
Pedcheck was used to detect non-Mendelian inheritance (O'Connell and Weeks, 1998).
When isolated Mendelian errors were observed, the genotypes for the entire family were
excluded for the marker yielding the error. Markers exhibiting a high rate of Mendelian
errors across families were excluded from subsequent analysis. Pedcheck identified 3104
Mendelian errors resulting in 7714 lost genotypes and the exclusion of one marker. To
further reduce errors, the error-checking algorithm implemented in MERLIN (Abecasis et
al., 2002) was used to assess the probability that each genotype was correctly called. A total
of 1867 genotypes with probabilities of less than 0.025 of being correct were removed from
further analysis. A total of 1867 problematic genotypes were identified and removed by
MERLIN. Following these quality control procedures, a total of 1,269,708 genotypes were
accepted with a success rate of 99.6%.
Analysis
Both genotype and phenotype data were available for 1647 individuals, and phenotype but
not genotype data were available for an additional 875 individuals (2 additional individuals
were lacking complete phenotype data). Seven hundred and thirteen families were
considered genetically informative for linkage analysis. Families that contained sibling, half-
sibling, avuncular or cousin pairs were included as being potentially genetically informative.
When considering all participants, these families ranged in size from 3 to 20 subjects
(average 2.90±2.44). The data includes: 1085 sibling, 40 half sibling, 17 grandparent-
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grandchild, 238 avuncular, and 32 cousin genetically-informative relative pairs. An
additional 177 families contained only a single individual with phenotype data. These
individuals were included within some analyses to the extent that they contributed
information about trait means and variance and the impact of covariates.
All linkage analyses were conducted using the variance components method implemented in
SOLAR (Almasy and Blangero, 1998). SOLAR is able to incorporate information from all
individuals in an extended pedigree whether it is a quantitative phenotype or a dichotomous
phenotype indicating affected and unaffected individuals. Though analyses of dichotomous
traits have lower statistical power than analyses of quantitative traits, this reduction in power
is less for dichotomous traits with high prevalence rates such as that observed for alcohol
dependence in the UCSF Family Alcoholism Study (Duggirala et al., 1997). Multipoint
LOD scores were calculated across the genome at 1 cM intervals. Because the UCSF Family
Alcoholism Study sample was selected for alcohol dependence, higher levels of antisocial
behavior, depressive symptoms, and impulsive substance use were anticipated (see Table 1
for correlations between dependence diagnoses and MMPI-2 scales). While only small
deviations of the MMPI-2 standardized scores from the expected mean of 50 were observed
(maximum deviation = +2.54 for the MAC-R scale), means for each scale were constrained
to 50 in the variance components models to correct for any bias due to ascertainment.
Initial linkage scans were conducted separately for the ASP, DEP, and MAC-R MMPI-2
scales. A second set of linkage scans were then conducted for each of these three scales
using DSM-IV alcohol and then cannabis dependence diagnostic status as covariates and
then as additional phenotypes in bivariate analyses. Alcohol and cannabis dependence were
separately analyzed as covariates for two reasons: (1) to provide parallel analyses to the
bivariate analyses that were conducted between each MMPI-2 scale and each diagnostic
variable and (2) because an evaluation of the linkage model suggested that cannabis
dependence diagnostic status was not a significant covariate after controlling for alcohol
dependence diagnostic status for any of the three MMPI scales, likely a result of the high
rates of alcohol dependence (79%) among individuals who met criteria for cannabis
dependence. The latter multivariate linkage analyses are conducted in SOLAR by estimating
the proportion of variance in each phenotype that can be explained by a genetic locus and
the extent to which the locus can explain the genetic correlation between phenotypes.
Linkage peaks exceeding a LOD score of 3.6 were reported as achieving genome-wide
significance and peaks exceeding a LOD score of 2.2 were reported as yielding suggestive
evidence for linkage as described by Lander and Kruglyak (1995). In addition, linkage peaks
exceeding a LOD score of 1.5 were reported as regions of interest. While these latter peaks
represent weaker evidence for linkage, reporting such findings may aid future studies and
meta-analytic reviews. To further aid in the interpretation of the results, empirical p-values
were calculated for reported linkage peaks by generating allele-sharing probabilities for a
simulated locus under the null hypothesis of no linkage across 100,000 trials (Duggirala et
al., 2001), an approach shown to yield appropriate Type I error rates (Jung et al., 2006). The
distribution of simulated LOD scores was used to calculate point-wise estimates of
significance. Support intervals for reported peaks were defined as the region surrounding a
linkage peak yielding a LOD score that was greater than the maximum LOD – 1 in each
direction.
Results
Analyses of the individual MMPI-2 scales yielded several loci that were suggestive of
linkage at the genome-wide level, though none achieved genome-wide significance (see
Table 2 for complete results). For the ASP scale, suggestive linkage peaks were observed on
chromosomes 13 at 11 cM (LOD=2.57, point-wise empirical P=0.00032) nearest marker
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D13S1304 with a support interval extending from 5–22 cM and chromosome 17 at 58 cM
(LOD=2.55, point-wise empirical P=0.00033) nearest marker D17S927 with a support
interval extending from 54–63 cM. For the DEP scale, a single locus of interest was
observed on chromosome 17 at 58 cM (LOD=1.71, point-wise empirical P=0.00200) nearest
marker D17S927 with a support interval extending from 47–67 cM. For the MAC-R scale, a
locus on chromosome 15 at 47 cM (LOD=3.25, point-wise empirical P=0.00004) nearest
markers D15S117 and D15S1033 with a support interval extending from 37–58 cM yielded
suggestive evidence for linkage. In addition, loci of interest were observed on chromosomes
3 at 218 cM (LOD=1.76, point-wise empirical P=0.00334) nearest markers D3S1265 with a
support interval extending from 202–225, 11 at 123 cM (LOD=1.62, point-wise empirical
P=0.00459) nearest markers D11S4094 with a support interval extending from 117–149, and
chromosome 17 at 57 cM (LOD=2.05, point-wise empirical P=0.00164) nearest markers
D17S927 with a support interval extending from 49–64.
To follow up these results, we repeated each genome scan with alcohol and then cannabis
dependence included as covariates to evaluate whether the observed findings could be
attributed to the MMPI-2 scales independent of alcohol or cannabis dependence diagnostic
status. The results of these analyses for the regions described above are shown in Table 3
alongside the corresponding results of linkage scans for alcohol and cannabis dependence
with and without the MMPI-2 scales included as covariates. The results examining the
overlap with alcohol dependence are described below. An inspection of Table 3 reveals
fluctuations of similar magnitudes were observed when examining the overlap with cannabis
dependence.
For the ASP scale, the linkage peak on chromosome 13 at 11 cM was strengthened (LOD
score increased from 2.57 to 3.03) when the presence of alcohol dependence was included as
a covariate, but the peak on chromosome 17 at 58 cM decreased in strength (LOD score
decreased from 2.55 to 2.08). For the DEP scale, the linkage peak on chromosome 17 at 58
cM decreased in strength (LOD score decreased from 1.71 to 1.11). For the MAC-R scale,
the strongest linkage peak, which was observed on chromosome 15 at 47 cM, decreased in
strength (LOD score decreased from 3.25 to 2.80) as did the peak observed on chromosome
17 at 57 cM (LOD score decreased from 2.05 to 1.97). In contrast, the peaks observed on
chromosomes 3 at 218 cM (LOD score increased from 1.76 to 2.12) and 11 at 123 cM (LOD
score increased 1.62 to 1.82) were both strengthened when the presence of alcohol
dependence was included as a covariate. In addition to these analyses, bivariate analyses of
each MMPI-2 scale and alcohol dependence diagnostic status were conducted to determine
whether this would yield LOD scores stronger than those observed in the univariate
analyses. These tended to yield results that were either weaker than or similar to the
univariate analyses of the MMPI-2 scales without alcohol dependence diagnostic status
included as a covariate (see Table 3). Further, there was no evidence to suggest linkage
between alcohol dependence and any of these genomic regions.
In conducting the described analyses, it was observed that the locus on chromosome 17 at
57–58 cM was reported as a region of interest for each of the MMPI-2 scales. To further
explore this result, a series of analyses spanning the support interval for this peak were
conducted to determine which scales were contributing to the evidence for linkage at this
locus. First, the evidence for linkage of each scale to this region was re-evaluated when the
two remaining scales were included as covariates in the analysis. For example in the analysis
of the ASP scale, the DEP and MAC-R scales were included as covariates. Second, a set of
bivariate analyses were run for each pair of scales with the remaining scale included as a
covariate in the analysis. Finally, a multivariate analysis was conducted including all three
scales. The results of these analyses are presented in Table 4. It was notable that including
the remaining two scales as covariates in the univariate analyses substantially reduced the
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LOD scores for each MMPI-2 scale, and further, the strongest result was observed for the
trivariate analysis including all 3 MMPI-2 scales (LOD=3.16), though this result was
weakened when alcohol or cannabis dependence diagnostic status was included in the
analysis as a covariate (LOD=2.78 and 2.96, respectively).
Discussion
The present study sought to identify genomic loci that confer risk for antisocial behavior,
depression, and impulsive substance use by conducting linkage scans of three scales from
the MMPI-2 that were constructed to measure these behaviors, the Antisocial Practices
content scale (ASP), the Depression content scale (DEP), and the revised MacAndrew
Alcoholism scale (MAC-R), respectively. Suggestive evidence of linkage was observed to
three genomic regions that proved independent of alcohol and cannabis dependence
diagnostic status. Specifically, the ASP scale showed evidence of linkage to chromosome 13
at 11 cM, the MAC-R scale showed evidence of linkage to chromosome 15 at 47 cM, and all
3 scales showed evidence of linkage to chromosome 17 at 57–58 cM. Of note, previous
linkage scans of alcohol and cannabis dependence conducted in the SFFAM failed to detect
evidence of linkage to any of these regions (Gizer et al., 2011 and Ehlers et al., 2010b,
respectively). This lack of overlap in findings is somewhat surprising given the evidence
from twin studies suggesting that common genetic influences underlie to some extent the
phenotypic correlations between the dependence diagnoses and antisocial behavior,
impulsive behavior, and even depression (e.g., Hicks et al., 2004; Kendler et al., 1993;
Young et al., 2006). It is possible that that the lack of overlap in findings between the
diagnoses and MMPI-2 scales could be due to the reduced power of variance components
linkage analysis for dichotomous traits, especially those with lower prevalence rates such as
cannabis dependence, relative to quantitative traits (Duggirala et al., 1997). Nonetheless, the
uniformly low LOD scores for the diagnostic variables in those linkage regions identified for
the MMPI-2 scales (all LODs <1.0) suggest that the discrepant results are not simply the
result of low power. Further, the relatively modest correlations between the dependence
diagnoses and the examined MMPI-2 scales in the UCSF sample (see Table 1) suggest that
these traits are largely distinct, thus providing a compelling explanation for the lack of
overlapping findings.
As described, the locus on chromosome 17 at 57–58 cM appeared to be linked to scores on
all three MMPI-2 scales that were evaluated. Further, the evidence for linkage was strongest
when the 3 scales were included in a multivariate analysis. It should be noted that these
scales do exhibit modest correlations in clinic-referred samples despite minimal item overlap
(Greene, 2000; see Table 1 for correlations in the UCSF Family Sample). Such correlations
clearly demonstrate overlap in what each scale is measuring, but they also demonstrate that
each scale is capturing unique information. Given the observed increase in LOD scores
when all 3 scales were considered in the analysis, it appears that the unique information
provided by each scale is contributing to the observed linkage signal. This would suggest
that the identified region on chromosome 17 is influencing psychopathology in some general
fashion rather than substance dependence, antisocial behavior, or depression specifically. As
an example, twin studies suggest the presence of genetic influences that jointly predispose
an individual to externalizing (e.g., antisocial behavior, substance dependence) and
internalizing disorders (e.g., major depressive disorder) (Cosgrove et al., 2011; O'Conner et
al., 1998). Low effortful control, which can manifest as high levels of reward seeking
behavior as well as high levels of negative emotionality, has been suggested by some
researchers as a broad risk factor for psychopathology that could account for the shared
genetic influences common to externalizing and internalizing disorders (MacDonald, 2008;
Nigg, 2006). Supporting the conclusion that this region might confer a broad risk for
psychopathology, studies have reported evidence of linkage to this region with a range of
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psychiatric disorders including major depressive disorder (Holmans et al., 2007; Middeldorp
et al., 2009), alcohol dependence (Hill et al., 2004), substance dependence (Gelernter et al.,
2006), and conduct disorder (Stallings et al., 2005; Stallings et al., 2003).
This chromosome 17 locus is located in a relatively gene-rich region and includes several
candidate genes that have been widely studied in relation to psychiatric disorders and related
phenotypes. For example, the gene encoding for the serotonin transporter (SLC6A4) is one
of the most widely studied genes in the psychiatric genetics literature and polymorphisms of
this gene have shown replicable evidence of association with disorders such as depression
(Lopez-Leon et al., 2008), alcohol dependence (McHugh et al., 2010), ADHD (Gizer et al.,
2009), and schizophrenia (Allen et al., 2008) in meta-analytic reviews. Additional candidate
genes in the region are involved in dopaminergic (PPP1R1B/DARPP32), noradrenergic
(PNMT), and cholinergic (VAT1) neurotransmission, neuronal development (MAPT,
NEUROD2), and the stress response hormone system (CRHR1). Given the diversity of
psychiatric phenotypes that have been related to this genomic region as well as the diversity
in neurobiological systems represented by potential candidate genes in the region, a
substantial amount of work will be required to refine our understanding of the observed
relations; however, preliminary findings such as those described in the present report as well
as those reviewed above suggest that this chromosomal region may either harbor several
genetic variants that each confer risk to a specific disorder, and/or genetic variants that
confer risk to psychopathology more broadly.
In addition to the locus on chromosome 17, suggestive evidence for linkage for the ASP
scale to chromosome 13 at 11 cM and for the MAC-R scale to chromosome 15 at 47 cM was
identified and proved to be independent of alcohol and cannabis dependence diagnostic
status. Both of these loci have shown evidence of linkage to phenotypically similar traits in
previous studies. For example, the locus on chromosome 13, which was linked to antisocial
behavior as measured by the ASP scale, has previously shown evidence of linkage to
externalizing behavior in a Native American population (Ehlers et al., 2008) as well as
tobacco use in the same Native American population (Ehlers and Wilhelmsen, 2006) and the
COGA sample (Saccone et al., 2003). Additionally, recent genome-wide association studies
have reported suggestive association signals in this region with several psychiatric disorders
including mood disorders (Huang et al., 2010), attention-deficit hyperactivity disorder
(ADHD) (Anney et al., 2008; Lasky-Su et al., 2010; Sonuga-Barke et al., 2008), and
schizophrenia (Sullivan et al., 2008) suggesting a relation between this region and
psychiatric phenotypes. Despite this convergence of findings to the described region, it is a
relatively gene-poor region without any obvious candidate genes, and the top hits reported in
several of the GWAS’s described above come from intergenic regions or genes that would
appear to lack a direct relation with psychiatric disorders.
The locus on chromosome 15, which was linked to impulsive substance use as assessed by
the MAC-R scale in the present study, has also shown previous evidence of linkage to
psychiatric phenotypes. For example, COGA has reported evidence of linkage between this
region and alcohol misuse related to heightened anxiety (Dick et al., 2002) and tobacco use
(Bierut et al., 2004), and evidence of linkage to this region for alcohol withdrawal was
reported in a Native American sample (Ehlers et al., 2004). Further, a locus approximately
50 cM telomeric has shown evidence of linkage to depression phenotypes in four previous
studies (Holmans et al., 2007; McGuffin et al., 2005; Middeldorp et al., 2009; Zubenko et
al., 2002). Notably, Terracciano and colleagues (2010) recently reported that a SNP in the
RORA gene located within the linkage region reported in the present study represented the
top hit in their GWAS of trait depression. This gene was also implicated in bipolar disorder
using a functional genomics approach integrating data from human and animal studies (Le-
Niculescu et al., 2009). Thus, it may be that the linkage signal reported for the MAC-R in
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the present study is related to cyclic changes in mood that co-occur with substance misuse.
Additional candidate genes in the region include two genes that encode for the glutamate
receptor, ionotropic, N-methyl D-aspartate-like 1A (GCOM1, GRINL1A) and CYP19A1,
which encodes for the aromatase enzyme responsible for the conversion of androgen to
estrogen.
Despite the potential importance of these findings, there are limitations of the present study
that should be considered. First, families in the UCSF Family Study sample were selected to
be enriched for the alcohol dependence diagnosis, and as a result, it is not clear how findings
from the present study will generalize to other populations. Second, it should be noted that
multiple phenotypes were evaluated in the present study, though corrections were not made
for multiple testing due to the generally low power of linkage analysis for complex traits.
Nonetheless, we attempted to limit spurious evidence for linkage by restricting follow-up
analyses (i.e., those including covariates and the multivariate analyses) to those regions of
interest identified in the initial univariate analyses. Third, the scales from the MMPI-2
included in the present study, while well-studied, have not been previously included in
molecular genetic studies of psychiatric disorders. Thus, replication of the reported results is
needed. Nonetheless, the convergence between the reported results and studies using
alternative assessment methods is promising.
In summary, the present study attempted to identify genetic loci that confer risk to antisocial
behavior, depressive symptoms, and impulsive substance use and reward-seeking behavior.
Suggestive evidence for linkage that was independent of alcohol and cannabis dependence
diagnostic status was observed between antisocial behavior and chromosome 13 at 11 cM
and between impulsive substance use and chromosome 15 at 47 cM. In addition, a region on
chromosome 17 at 57–58 cM showed evidence of linkage in a multivariate analysis to
antisocial behavior, depressive symptoms, and impulsive substance use. These regions have
shown prior evidence of linkage and association to substance dependence and externalizing
behavior as well as other psychiatric disorders such as depression suggesting potentially
broad relations with psychopathology.
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Multipoint linkage analysis for the Antisocial Practices (ASP), Depression (DEP), and
MacAndrew Revised Alcoholism (MAC-R) MMPI-2 scales. Chromosome numbers are
displayed on the x-axis, and LOD scores are displayed on the y-axis. Results for each
chromosome are aligned end to end with the pterminus on the left. Vertical lines indicate the
boundaries between chromosomes.
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Table 1








DEP 0.193 0.067b 0.418
MAC-R 0.312 0.095 0.465 0.215
Notes: p-values for all bivariate correlations were <0.001 except for
a
p = 0.001 and
b
p = 0.010.
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